1. High expression of adhesion molecules/activation markers with little interleukin-2, interferon γ, and tumor necrosis factor β gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma

   • Eugène Roussel
   • Marie-Claude Gingras
   • Jack A. Roth

   Original Article Pages: 1 - 9

2. Therapy of bovine ocular squamous-cell carcinoma with local doses of interleukin-2: 67% complete regressions after 20 months of follow-up

   • Willem Den Otter F. W.
   • Graham Hill
   • Victor P. M. G. Rutten

   Original Article Pages: 10 - 14

3. Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells

   • Cecilia Ballaré
   • Marcela Barrio
   • Jose Mordoh

   Original Article Pages: 15 - 22

4. Interferons up-regulate with different potency HLA class I antigen expression in M14 human melanoma cell line. Possible interaction with glucocorticoid hormones

   • Lorella Lanza
   • Lorenza Peirano
   • Marco Scudeletti

   Original Article Pages: 23 - 28

5. Pharmacokinetics of anti-ganglioside GD2 mAb 14G2a in a phase I trial in pediatric cancer patients

   • Martina M. Uttenreuther-Fischer
   • Chuin-Sheng Huang
   • Alice L. Yu

   Original Article Pages: 29 - 36

6. Treating tumor-bearing mice with vitamin D₃ diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence

   • M. Rita I. Young
   • Joe Ihm
   • M. Margaret Prechel

   Original Article Pages: 37 - 45

7. Antibody-independent phagocytosis of tumor cells by human monocyte-derived macrophages cultured in recombinant macrophage colony-stimulating factor

   • David H. Munn
   • Nai-Kong V. Cheung

   Original Article Pages: 46 - 52

8. In vitro and in vivo antitumour activity of a chimeric anti-CD19 antibody

   • Geoffrey A. Pietersz
   • Li Wenjun
   • Joseph A. Trapani

   Original Article Pages: 53 - 60

9. Lymphocytes infiltrating colorectal cancer have low proliferative capacity but can secrete normal levels of interferon γ

   • Wendy J. Bateman
   • Imelda Donnellan
   • Alan G. Morris

   Original Article Pages: 61 - 67

10. Graft-versus-host disease following interleukin-2/lymphokine-activated killer (LAK) cell immunotherapy in a patient with acute myelogenous leukaemia in second complete remission: autologous LAK cells following allogeneic bone marrow transplantation are donor-derived

    • Brian J. Boughton
    • Andrew W. Simpson
    • Cynthia Beatty

    Short Communication Pages: 68 - 70